Verify the purchasing entity and authority
Record the legal entity, procurement owner, professional role and the authorizations relevant to its planned activity. A familiar brand name is not a substitute for exact entity and scope.
Germany procurement questions
Screen the German route before advancing the product.
A potential product match is only the starting point. The buyer still needs a transaction-specific view of authority, import permissions, product stage, manufacturing and release responsibilities, batch evidence and commercial basis.
For licensed and otherwise authorized commercial operators. Not for patients or consumers. This is operational procurement information, not German legal or regulatory advice.
Before supplier names
Define the German-side operating chain.
Germany's Medizinal-Cannabisgesetz addresses permission requirements for handling medical cannabis and separate approvals for import and export. The exact entities, activities and exemptions must be checked for the real transaction.
Specify the product and intended stage
State whether the buyer wants starting material, material for further processing, or a product at a defined manufacturing, certification or release stage.
Name the importer and permission path
Identify who would import, which permission or exemption is relied on, who obtains shipment-specific approvals where applicable, and which facts still need authority or counsel confirmation.
Map manufacturing, testing and release
Identify every material step, the responsible facility, its scope, the required testing, the responsible qualified professionals and the evidence supporting the proposed route.
Normalize price and allocate risk
Compare candidates at the same delivery stage and named place. Keep unpriced conversion, loss, testing, freight, duties, release and rejection/return responsibilities visible.
Germany screen
What a usable buyer brief should contain.
Commercial requirement
- Product form and exact specification
- One-time or recurring kg range
- Need date and decision timeline
- Target price and delivery basis
- Approved substitutes and hard exclusions
Responsible parties
- German buyer and procurement owner
- Importer and relevant permissions
- Processor/manufacturer and facility scope
- Testing and release responsibilities
- Named place, custody and risk transfer
Current lot and documents
- Lot ID and availability date
- Allocable kg and MOQ
- Lot-linked reports
- License/certificate source and scope
- Unknown, pending and stale items
Do not collapse these questions
Five labels that do not prove the route.
| Label | What it may support | What still needs to be established |
|---|---|---|
| “GACP” | A claim or document concerning cultivation/collection and primary processing | Entity, issuer, scope, current status, lot linkage and all downstream steps |
| “EU-GMP” | A claim or certificate concerning a named manufacturing site and activities | Exact entity, site, authorized activities/product scope, current status and relevance to this product |
| “Export ready” | A supplier's view that it can support an export | Origin authorization, destination importer, permits, documents, timing and shipment-specific facts |
| “QP pathway” | A proposed certification/release arrangement | Named licensed party, accepted scope, testing, dossier/technical basis, responsibilities and written commercial terms |
| “DAP Germany” | A proposed delivery basis and place | Exact named place, Incoterms version, inclusions, importer/customs roles, title/risk and release responsibilities |
A route diagram is not approval. Before an introduction, recheck the named entities, current records, scope, responsible parties and the exact product and shipment assumptions.
Provenance's role
Commercial origination without taking the regulated role.
Provenance can structure the requirement, compare public-safe or permitted evidence, surface route gaps and coordinate a protected introduction. The licensed counterparties decide regulatory, quality and product acceptance and transact directly.
No custody
Provenance does not purchase, possess, ship, import, manufacture or release product.
No automatic approval
A screen, evidence tag or introduction is not regulatory certification or quality acceptance.
Controlled disclosure
Supplier identity and restricted documents remain gated until the applicable authority, route, permission and commercial protections are clear.
Primary German and EU sources
Use the current text and exact scope.
- Germany: Medizinal-Cannabisgesetz (MedCanG) — current consolidated federal text and table of contents.
- MedCanG § 4 — permission requirement for listed activities, subject to the statute's terms and exceptions.
- MedCanG § 12 — import and export approvals.
- European Commission: EudraLex Volume 4 — EU GMP guidance, including Annex 16.
- EudraGMDP — manufacturing/import authorization and GMP certificate records.
Source boundary: this page summarizes questions for commercial screening. It does not determine whether any entity, product, activity or shipment is authorized. Check current German/EU sources and obtain transaction-specific advice from the responsible licensed parties and qualified advisers.
Germany requirement
Bring the product, destination and route you need.
We will identify a credible fit, the decisive missing information, or a clear no-fit answer before identities are disclosed.